Search News

Corporate Industry Technology Medical Updates

Mechanical Circulatory Support

Corporate
MoyoAssist® Launched! The Mid-to-Short-Term MCS Forum and Extra-VAD Clinical Technology Transformation Results Conference Successfully Held 2024-06-24
Corporate
NMPA grants approval to MoyoAssist® China's first full maglev extracorporeal VAD 2024-05-14
Corporate
magAssist Forges University-Enterprise Cooperation with Domestic and International Universities to Empower Innovative Talents Cultivation Scheme 2023-01-12
Medical Updates
The FIRST transseptal cannulation treatment via MoyoAssist Extra-VAD 2022-08-24
Corporate
Happy 5th Anniversary to magAssist!!! 2022-05-12
Medical Updates
Professor Ping Li "Extra-VAD, could be a greater life-support solution for Bridging to Heart Transplantation" 2021-07-30
Corporate
magAssist's extracorporeal ventricular assist device Debuts at 2021 China International Heart Failure Conference 2021-07-16
Technology
magAssist's extracorporeal artificial heart product made the first public appearance at an international academic conference 2019-11-28
Technology
Dr. Po-Lin Hsu, magAssist founder, was elected as a member of ISMCS committee. 2019-11-26
Technology
The First Mechanical Circulatory Support Symposium (MCSS) in Suzhou 2018-10-31

Tabs： artificial organs, interventional therapy, Percutaneous VAD, life support in case of multi-organ failure, a short-term full maglev ventricular assist device, critical care life support scenarios, minimally-invasive, How Artificial Heart Works, a leading company in treating heart failures, short-term bridging heart transplant patients, Conference,